Stoke Therapeutics, Inc. (STOK)

Healthcare · Biotechnology · NASDAQ

Stoke Therapeutics, Inc. (STOK) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.11B and a free-cash-flow yield of 2.3%. Over the most recent reported fiscal year, revenue grew 404.5%.

Market cap	$2.11B
Trailing P/E	—
FCF yield	2.3%
Revenue growth (YoY)	+404.5%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live STOK data on Nama Insights →